Microbiome and Metabolome Profiles Associated With Different Types of Short Bowel Syndrome: Implications for Treatment

Abstract

Background:The gut microbiome and metabolome may significantly influence clinical outcomes in patients with short bowel syndrome (SBS). The study aimed to describe specific metagenomic/metabolomics profiles of different SBS types and to identify possible therapeutic targets. Methods: Fecal microbiome (FM), volatile organic compounds (VOCs), and bile acid (BA) spectrum were analyzed in parenteral nutrition (PN)-dependent SBS I, SBS II, and PN-independent (non-PN) SBS patients. Results: FM in SBS I, SBS II, and non-PN SBS shared characteristic features (depletion of beneficial anaerobes, high abundance of Lactobacilaceae and Enterobacteriaceae). SBS I patients were characterized by the abundance of oxygen-tolerant microrganisms and depletion of strict anaerobes. Non-PN SBS subjects showed markers of partial FM normalization. FM dysbiosis was translated into VOC and BA profiles characteristic for each SBS cohort. A typical signature of all SBS patients comprised high saturated aldehydes and medium-chain fatty acids and reduced short-chain fatty acid (SCFA) content. Particularly, SBS I and II exhibited low protein metabolism intermediate (indole, p-cresol) content despite the hypothetical presence of relevant metabolism pathways. Distinctive non-PN SBS marker was high phenol content. SBS patients' BA fecal spectrum was enriched by chenodeoxycholic and deoxycholic acids and depleted of lithocholic acid. Conclusions: Environmental conditions in SBS gut significantly affect FM composition and metabolic activity. The common feature of diverse SBS subjects is the altered VOC/BA profile and the lack of important products of microbial metabolism. Strategies oriented on the microbiome/metabolome reconstitution and targeted delivery of key compounds may represent a promising therapeutic strategy in SBS patients. (JPEN J Parenter Enteral Nutr. 2020;44:105-118) Keywords bile acids; gut microbiota; parenteral nutrition; short bowel syndrome, short-chain fatty acids, volatile organic compounds From the

Antibiotic-driven intestinal dysbiosis in pediatric short bowel syndrome is associated with persistently altered microbiome functions and gut-derived bloodstream infections

“…Consistent with previous reports, 10–12 , 14 we find that GM diversity is decreased in SBS compared to term children and that this signature persists throughout the first four years of life. We identify antibiotic exposure as the main driver of diminished GM diversity in SBS.…”

“…We comprehensively evaluated taxonomic, functional, and resistome correlates of SBS by comparing them to two agematched cohorts of term and preterm infants recruited in the same hospital system. Consistent with previous reports, [10][11][12]14 we find that GM diversity is decreased in SBS compared to term children and that this signature persists throughout the first four years of life. We identify antibiotic exposure as the main driver of diminished GM diversity in SBS.…”

“…Diversity and richness of the gut microbiota (GM) in children with SBS are lower than corresponding indices in age-matched controls. [10][11][12] The SBS GM is characterized by increased abundance of Enterobacteriaceae and depletion of short-chain fatty acid-producing obligate anaerobes, 10,11,13 an imbalance that has been associated with poor growth. 14 While prior work has identified the GM as a determinant of successful weaning from PN, conclusions are limited by sample size, lack of suitable age-matched preterm and term controls, and crosssectional nature of comparisons.…”

Nonthyroidal Illness Syndrome in Patients With Short‐Bowel Syndrome

“…Insulin and leptin levels in energy restriction conditions are decreased, which inhibits deiodination and thyrotropic adaptation 30 . Patients with SBS have altered bile acids metabolomic profiles owing to the disrupted enterohepatic circulation 31 . The loss of the enterohepatic recirculation of bile acids can reduce the reabsorption of bile‐conjugated iodothyronines and, consequently, inhibit the effect of bile acids in energy expenditure by promoting intracellular TH activation 32‐34 .…”

Caloric restriction increases levels of taurine in the intestine and stimulates taurine uptake by conjugation to glutathione

“…The quantification protocol was adapted from the method of Ito et al (Ito et al, 2018) and Budinska et al (Budinska et al, 2020). Frozen liver and intestinal mucosa samples were cut on dry ice to the size of 7-10 mg and homogenized.…”